Courier Capital’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$315K Sell
108,500
-61,500
-36% -$221K 0.02% 339
2026
Q2
$702K Buy
170,000
+82,500
+94% +$364K 0.04% 249
2026
Q1
$316K Sell
87,500
-12,500
-13% -$43.2K 0.02% 323
2025
Q4
$341K Sell
100,000
-20,000
-17% -$97.1K 0.02% 310
2025
Q3
$815K Hold
120,000
– – 0.05% 231
2025
Q2
$1.63M Hold
120,000
– – 0.1% 174
2025
Q1
$653K Buy
+120,000
New +$681K 0.04% 240

Other funds holding LFMD

Courier Capital's LFMD Position: Q3 2026 in Review

Courier Capital reduced its LifeMD (LFMD) stake by 36% in Q3 2026, selling an estimated $221K and leaving 108,500 shares worth $315K. The position accounts for 0.02% of the portfolio, ranked #339.

Courier Capital first reported a position in LFMD in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.63M in Q2 2025. 45 funds tracked by Wall St. Rank hold LFMD as of Q3 2026.

  • Courier Capital held 108,500 shares of LifeMD worth $315K as of Q3 2026.
  • Courier Capital sold 61,500 LifeMD shares in Q3 2026, an estimated $221K.
  • LifeMD made up 0.02% of Courier Capital's portfolio in Q3 2026, its #339 holding.
  • Courier Capital first reported a position in LifeMD in Q1 2025 and has held it in 7 quarters since.
  • Courier Capital's LifeMD position peaked at $1.63M in Q2 2025.
  • 45 funds tracked by Wall St. Rank held LifeMD as of Q3 2026.

Based on Courier Capital's 13F filing for Q3 2026, filed 13 Oct 2026.